Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
05/2010
05/19/2010CN101049320B Buccal tablets of extractive of propolis alcohol
05/19/2010CN101040891B Method of preparing tripterygium hypoglaucum (Levl) hutch alkaloids
05/19/2010CN101032610B Medicinal liquor with Chinese medicine for treating rheumatoid disease and its preparation
05/19/2010CN101032580B Medicine for treating rheumatic diseases
05/19/2010CN101028506B Chinese-medicinal decoction for treating difficult menstruation
05/19/2010CN101028504B Gubiping instant granules and production thereof
05/19/2010CN101028472B Oral Chinese medicinal composition for treating lumbocostal overstrain
05/19/2010CN101028461B Job's tears nut oil self-emusifying preparation and its making method
05/19/2010CN101028406B Chinese-medicinal decoction for treating difficult menstruation
05/19/2010CN101028405B Chinese-medicinal decoction for treating difficult menstruation
05/19/2010CN101028077B Method for preparing cactus nutrient dried brown rice vermicelli
05/19/2010CN101024003B Medicine for treating injury and preparing method
05/19/2010CN101023990B Chinese readymade medicine for treating exogenous disease
05/19/2010CN101015326B Wax-free aged honeycomb beverage and its preparing process
05/19/2010CN100998592B Microemulsion containing matrine
05/18/2010USRE41339 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use
05/18/2010US7718702 Cannabinoid receptor ligands
05/18/2010US7718698 Adding fatty acid ester, a fatty acid amide, a free fatty acid or a hydrocarbon, to a mixture of a fat or an oil, being edible or for use in cosmetics; stripping and separating the environmental pollutant present in the fat or oil
05/18/2010US7718658 Saturated ring with 2 nitrogens, 1 of which is 2-(o-(difluoromethyl)phenyl)quinazol-4-yl-substituted and the other is oxyalkanoyl-substituted; inhibitors of voltage-gated sodium channels and calcium channels; treating acute, chronic, neuropathic, or inflammatory pain
05/18/2010US7718654 Substituted pteridines for the treatment of inflammatory diseases
05/18/2010US7718382 Method for identifying compounds for treatment of pain
05/18/2010US7718177 Antibodies directed to fragments of connective tissue growth factor (CTGF) polypeptide and methods and uses thereof
05/18/2010CA2555429C Stable injectable diclofenac compositions
05/18/2010CA2465247C Benzimidazoles and analogues and their use as protein kinases inhibitors
05/18/2010CA2422371C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2422367C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2401498C New self emulsifying drug delivery system
05/18/2010CA2339667C Method of using tetracycline compounds to enhance interleukin-10 production
05/18/2010CA2304204C Quinoline-containing .alpha.-ketoamide cysteine and serine protease inhibitors
05/18/2010CA2302808C 50 human secreted proteins
05/18/2010CA2259143C G-beta-gamma regulated phosphatidylinositol-3' kinase p101 regulatory subunit
05/14/2010WO2010054279A1 Compounds for the treatment of inflammatory disorders
05/14/2010WO2010054260A1 Imidazo[5,1-c][1,2,4]benzotriazine derivatives as inhibitors of phosphodiesterases
05/14/2010WO2010054126A2 Small molecule modulators of epigenetic regulation and their therapeutic applications
05/14/2010WO2010054058A1 Imidazolothiazole compounds as modulators of protein kinase
05/14/2010WO2010054024A2 Novel compounds as cannabinoid receptor ligands
05/14/2010WO2010054015A2 Methods of reducing the risk of cardiovascular disease in postmenopausal women
05/14/2010WO2010053978A2 Modulation of toll-like receptor 5 expression by antisense oligonucleotides
05/14/2010WO2010053902A2 Tryptase enzyme inhibiting aminothiophenols
05/14/2010WO2010053182A1 Kynurenine production inhibitor
05/14/2010WO2010052896A1 Preparation for local administration containing fluticasone propionate
05/14/2010WO2010052228A1 Hla-g proteins and pharmaceutical uses thereof
05/14/2010WO2010051977A1 Substituted disulfonamides as bri-modulators
05/14/2010WO2010027189A9 A new use for homoisoflavanone or a salt thereof
05/14/2010WO2010021882A3 Cold menthol receptor antagonists
05/14/2010WO2010019210A3 Halofuginone analogs for inhibition of trna synthetases and uses thereof
05/14/2010WO2010009892A3 Compositions for the treatment of pain and/or inflamation
05/14/2010WO2009153434A3 Synthetic analogues of phosphatidyl-myo-inositol mannosides with an inhibitory activity on the inflammatory response
05/14/2010WO2009152167A3 Delivery of therapeutics
05/14/2010WO2009041799A8 Pharmaceutical composition combining diacerein and chondroitin sulphate and use thereof in the treatment of osteoarthritis and related diseases
05/14/2010WO2009041798A8 Pharmaceutical compositions combining a nonsteroidal anti-inflammatory agent and a xanthine oxidase inhibiting agent, which can be used to control and treat gout, gouty arthritis and related diseases
05/14/2010CA2746054A1 Small molecule modulators of epigenetic regulation and their therapeutic applications
05/14/2010CA2742741A1 Substituted disulfonamides
05/14/2010CA2742531A1 Modulation of toll-like receptor 5 expression by antisense oligonucleotides
05/14/2010CA2742517A1 Hla-g proteins and pharmaceutical uses thereof
05/14/2010CA2741047A1 Novel compounds as cannabinoid receptor ligands
05/13/2010US20100121255 Compound
05/13/2010US20100120918 Novel non-aqueous topical solution of diclofenac and process for preparing the same
05/13/2010US20100120909 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
05/13/2010US20100120903 Anti-inflammatory agent
05/13/2010US20100120902 Standarized bioactive herbal extracts
05/13/2010US20100120883 Novel compounds
05/13/2010US20100120869 Compounds and methods for pkc theta inhibition
05/13/2010US20100120865 thiazol-2-yl-urea derivatives such as 3-{3-[4-Methyl-5-(4-pyrazol-1-yl-phenyl)-thiazol-2-yl]-ureido}-N-pyridin-3-yl-propionamide, used in the treatment of diseases ameloriated by inhibition of phosphatidylinositol 3-kinase, particularly inflammatory, allergic or autoimmune conditions
05/13/2010US20100120852 Aroyl-piperidine derivatives and method of treating disorders induced by substance p
05/13/2010US20100120846 Trpv1 antagonists
05/13/2010US20100120839 Pyrazoles useful in the treatment of inflammation
05/13/2010US20100120838 Compounds for the treatment of inflammatory disorders
05/13/2010US20100120804 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
05/13/2010US20100120802 Novel Anti-Inflammatory and Analgesic Heterocyclic Amidines that Inhibit Nitrogen Oxide (NO) Production
05/13/2010US20100120799 Purine derivatives as immunomodulators
05/13/2010US20100120798 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety
05/13/2010US20100120794 Cycloalkylamino Acid Derivatives
05/13/2010US20100120783 Melanocortin receptor agonists
05/13/2010US20100120778 Quinoxaline-based lxr modulators
05/13/2010US20100120767 Pyrimidothiophene Compounds
05/13/2010US20100120766 Substituted Pteridines
05/13/2010US20100120762 Triazine derivatives as inhibitors of phosphodiesterases
05/13/2010US20100120749 Tetrahydroindole derivatives as nadph oxidase inhibitors
05/13/2010US20100120731 3-([1,2,4]triazolo [4,3-a]pyridin-7-yl)benzamide derivatives
05/13/2010US20100120719 Lyophilization formulation
05/13/2010US20100120717 Kinase inhibitors
05/13/2010US20100120704 Cardiac glycosides to treat cystic fibrosis and other IL-8 dependent disorders
05/13/2010US20100120694 Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
05/13/2010US20100120015 Method of collecting placental stem cells
05/13/2010US20100119694 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
05/13/2010US20100119633 Analgesic oil containing plant based extracts from solar infusions
05/13/2010US20100119603 Nanoparticles comprising a drug,ethycellulose,and a bile salt
05/13/2010US20100119580 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
05/13/2010US20100119530 Regulation of TLR Signaling by Complement
05/13/2010US20100119503 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
05/13/2010US20100119478 ANTIBODIES DIRECTED AGAINST PYROGLUTAMATE MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1 N1pE)
05/13/2010US20100119453 Methods of enhancing functioning of the large intestine
05/12/2010EP2184355A1 Antibody modified with hydrophobic molecule
05/12/2010EP2184281A1 Phenyl-thiophene type vitamin D receptor modulators
05/12/2010EP2184278A1 P2x4 receptor antagonist
05/12/2010EP2184070A1 HLA-G proteins and pharmaceutical uses thereof
05/12/2010EP2183251A1 Indazole compounds for treating inflammatory disorders, demyelinating disorders and cancers
05/12/2010EP2183247A1 New crystalline forms of 2 -hydroxy- 3- ý5- (morpholin- 4- ylmethyl) pyridin-2-yl¨ih- indole- 5 -carbonitrile citrate
05/12/2010EP2183241A2 2-pyridine carboxamide derivatives as sodium channel modulators
1 ... 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 ... 1272